Page last updated: 2024-08-16

ranitidine and Hematologic Malignancies

ranitidine has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bachy, E; Baudouin, A; Bouafia-Sauvy, F; Bourbon, E; Caffin, AG; Gouraud, A; Henin, E; Karlin, L; Ranchon, F; Rioufol, C; Salles, G; Sarkozy, C; Schwiertz, V; Vantard, N; Vial, T	1

Other Studies

1 other study(ies) available for ranitidine and Hematologic Malignancies

Article	Year
Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences? Hematological oncology, 2018, Volume: 36, Issue:2 Topics: Adult; Aged; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Female; Hematologic Neoplasms; Humans; Male; Methotrexate; Middle Aged; Proton Pump Inhibitors; Ranitidine; Retrospective Studies; Time Factors	2018

Article

Year

Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?

Hematological oncology, 2018, Volume: 36, Issue:2

Topics: Adult; Aged; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Female; Hematologic Neoplasms; Humans; Male; Methotrexate; Middle Aged; Proton Pump Inhibitors; Ranitidine; Retrospective Studies; Time Factors

2018